Dr. Jane Reznick - Curriculum Vitae
Education and Professional Career
since 2020: Research Group Leader, CECAD Research Centre, University Hospital Cologne
2012 – 2019: Postdoctoral researcher, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany
2007 – 2012: Doctorate, Garvan Institute of Medical Research, University of New South Wales, Sydney, Australia
2002 – 2006: Bachelor of Advanced Science (Molecular Biology) with Honours, University of NSW, Australia
Awards, Distinctions and Scientific Activities
2026: ERC PoC (NEWHEART)
since 2025: Member of the Strategy Board for University of Cologne’s application for the University of Excellence
2024: Participant, DFG Site Visit for CECAD Excellence Cluster Renewal, Bonn
2024: Organizer of Scientific Meeting BIOMORA24 “Unique biology of African Mole-Rats: from husbandry to biomedical applications”, Bonn, Germany
2024: Co-Organizer and Chair of Scientific Meeting “The Cologne Aging Conference”, Cologne, Germany
2024: DFG, German Research Foundation - International Scientific Events (BIOMORA24 “Unique biology of African Mole-Rats)
2023: Associate Editor for Nature Portfolio Metabolism Journal (Metabolism Health and Disease)
since 2023: Deputy member of the CECAD Executive Board
2023: Organizer of the CECAD Group Leader Retreat
2022: Organizer of the Inaugural CECAD Junior Group Leader Retreat
2021-2023: Member of the CECAD Executive Board
since 2021: Representative of CECAD Group Leaders
since 2020: Peer-Reviewing for Scientific Journals (Nature Communications, Science Advances, Genome Research, Journal of Investigative Dermatology, Nature communications biology)
2019: Organizer and Chair of EMBO Workshop “Beyond the Standard: Non-model vertebrates in biomedicine”, Berlin, Germany
2019: ERC Starting Grant (METAMOLE commenced Jan 2021)
2018: EMBO Workshop Grant
2018: DFG, German Research Foundation - International Scientific Events (EMBO Workshop: Beyond the Standard)
2018: BHI Validation Fund Track 2, Berlin Institute for Health and Berlin Health Innovations
2017: PreGo Bio Funding, Max Delbrück Center for Molecular Medicine in the Helmholtz Association
2017: Spark Berlin (Mentorship Program and Funding), Berlin Institute of Health and Stiftung Charité
2016: BIH Technology Transfer Fund – Pharma, Berlin Institute of Health